Defining Burkitt's lymphoma (BL) with cytogenetics:  LY10, a prospective clinicopathological study of dose-reduced (dr) CODOX-M/IVAC in patients with 100% Ki-67 staining B-cell non-Hodgkin's lymphoma (NHL).

J. Walewski; G. Mead; A. Jack; S. Barrans; J. Radford; S. Clawson; S. Stenning; W. Qian; Natl Canc Res Inst Lymphoma Gr

Defining Burkitt's lymphoma (BL) with cytogenetics: LY10, a prospective clinicopathological study of dose-reduced (dr) CODOX-M/IVAC in patients with 100% Ki-67 staining B-cell non-Hodgkin's lymphoma (NHL).

J. Walewski
, G. Mead
, A. Jack
, S. Barrans
, J. Radford
, S. Clawson
, S. Stenning
, W. Qian
, Natl Canc Res Inst Lymphoma Gr

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	436S
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	24
Issue number	18
Publication status	Published - 20 Jun 2006
Event	42nd Annual Meeting of the American-Society-of-Clinical-Oncology - Atlanta, United States Duration: 2 Jun 2006 → 6 Jun 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Walewski, J., Mead, G., Jack, A., Barrans, S., Radford, J., Clawson, S., Stenning, S., Qian, W., & Gr, N. C. R. I. L. (2006). Defining Burkitt's lymphoma (BL) with cytogenetics: LY10, a prospective clinicopathological study of dose-reduced (dr) CODOX-M/IVAC in patients with 100% Ki-67 staining B-cell non-Hodgkin's lymphoma (NHL). Journal of Clinical Oncology, 24(18), 436S.

@article{23403701dc214c84a72810d57720c295,

title = "Defining Burkitt's lymphoma (BL) with cytogenetics: LY10, a prospective clinicopathological study of dose-reduced (dr) CODOX-M/IVAC in patients with 100\% Ki-67 staining B-cell non-Hodgkin's lymphoma (NHL).",

author = "J. Walewski and G. Mead and A. Jack and S. Barrans and J. Radford and S. Clawson and S. Stenning and W. Qian and Gr, \{Natl Canc Res Inst Lymphoma\}",

year = "2006",

month = jun,

day = "20",

language = "English",

volume = "24",

pages = "436S",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "18",

note = "42nd Annual Meeting of the American-Society-of-Clinical-Oncology ; Conference date: 02-06-2006 Through 06-06-2006",

}

Walewski, J, Mead, G, Jack, A, Barrans, S, Radford, J, Clawson, S, Stenning, S, Qian, W & Gr, NCRIL 2006, 'Defining Burkitt's lymphoma (BL) with cytogenetics: LY10, a prospective clinicopathological study of dose-reduced (dr) CODOX-M/IVAC in patients with 100% Ki-67 staining B-cell non-Hodgkin's lymphoma (NHL).', Journal of Clinical Oncology, vol. 24, no. 18, pp. 436S.

Defining Burkitt's lymphoma (BL) with cytogenetics: LY10, a prospective clinicopathological study of dose-reduced (dr) CODOX-M/IVAC in patients with 100% Ki-67 staining B-cell non-Hodgkin's lymphoma (NHL). / Walewski, J.; Mead, G.; Jack, A. et al.
In: Journal of Clinical Oncology, Vol. 24, No. 18, 20.06.2006, p. 436S.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Defining Burkitt's lymphoma (BL) with cytogenetics

T2 - 42nd Annual Meeting of the American-Society-of-Clinical-Oncology

AU - Walewski, J.

AU - Mead, G.

AU - Jack, A.

AU - Barrans, S.

AU - Radford, J.

AU - Clawson, S.

AU - Stenning, S.

AU - Qian, W.

AU - Gr, Natl Canc Res Inst Lymphoma

PY - 2006/6/20

Y1 - 2006/6/20

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000239009403045&KeyUID=WOS:000239009403045

M3 - Meeting Abstract

SN - 0732-183X

VL - 24

SP - 436S

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 18

Y2 - 2 June 2006 through 6 June 2006

ER -

Defining Burkitt's lymphoma (BL) with cytogenetics: LY10, a prospective clinicopathological study of dose-reduced (dr) CODOX-M/IVAC in patients with 100% Ki-67 staining B-cell non-Hodgkin's lymphoma (NHL).

UN SDGs

Other files and links

Cite this